Application of a bacteriophage cocktail to reduce Salmonella Typhimurium U288 contamination on pig skin

International Journal of Food Microbiology

Volumn 151, Issue 2, 2011, Pages 157-163

  Hooton, Steven P T ^a   Atterbury, Robert J ^a   Connerton, Ian F ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Bacteriophage (phage); Biosanitization; Phage therapy; Salmonella Typhimurium U288

Indexed keywords

ARTICLE; BACTERIAL COUNT; BACTERIOPHAGE; BACTERIUM CONTAMINATION; CARCASS; COLONY FORMING UNIT; FOOD CONTAMINATION; FOOD STORAGE; MEAT; NONHUMAN; SALMONELLA ENTERICA; SALMONELLA TYPHIMURIUM; SWINE;

ANIMALS; FOOD CONTAMINATION; FOOD MICROBIOLOGY; SALMONELLA INFECTIONS, ANIMAL; SALMONELLA PHAGES; SALMONELLA TYPHIMURIUM; SKIN; SWINE; SWINE DISEASES;

BACTERIA (MICROORGANISMS); SALMONELLA; SALMONELLA ENTERICA; SALMONELLA TYPHIMURIUM; SUIDAE;

EID: 80054080060     PISSN: 01681605     EISSN: 18793460     Source Type: Journal    
DOI: 10.1016/j.ijfoodmicro.2011.08.015     Document Type: Article

References (52)

1. Allison H.E. Stx-phages: drivers and mediators of the evolution of STEC and STEC-like pathogens. Future Microbiology 2007, 2:165-174.
2. Atterbury R.J., Van Bergen M.A.P., Ortiz F., Lovell M.A., Harris J.A., De Boer A., Wagenaar J.A., Allen V.M., Barrow P.A. Bacteriophage therapy to reduce Salmonella colonization of broiler chickens. Applied and Environmental Microbiology 2007, 73:4543-4549.
3. Beutin L. Emerging enterohaemorrhagic Escherichia coli, causes and effects of the rise of a human pathogen. Journal of Veterinary Medicine 2006, 53:299-305.
4. Bigwood T., Hudson J.A., Billington C. Influence of host and bacteriophage concentrations on the inactivation of food-borne pathogenic bacteria by two phages. FEMS Microbiology Letters 2009, 291:59-64.
5. Boyen F., Haesebrouck F., Maes D., Van Immerseel F., Ducatelle R., Pasmans F. Non-typhoidal Salmonella infections in pigs: a closer look at epidemiology, pathogenesis and control. Veterinary Microbiology 2008, 130:1-19.
6. Bruun T., Sørenson G., Forshell L.P., Jensen T., Nygard K., Kapperud G., Lindstedt B.A., Berglund T., Wingstrand A., Peterson R.F., Müller L., Kjelsø C., Ivarsson S., Hjertqvist M. An outbreak of Salmonella Typhimurium infections in Denmark, Norway, and Sweden, 2008. Euro Surveillance 2009, 14:10.
7. Cairns B.J., Payne R.J.H. Bacteriophage therapy and the mutant selection window. Antimicrobial Agents and Chemotherapy 2008, 52:4344-4350.
8. Cairns B.J., Timms A.R., Jansen V.A.A., Connerton I.F., Payne R.J.H. Quantitative models of in vitro bacteriophage-host dynamics and their application to phage therapy. PLOS Pathogens 2009, 5:1-10.
9. Callaway T.R., Edrington T.S., Brabban A., Kutter E., Karriker L., Stahl C., Wagstrom E., Anderson R.C., Genovese K., McReynolds J., Harvey R., Nisbet D.J. Occurrence of Salmonella-specific bacteriophages in swine feces collected from commercial farms. Foodborne Pathogens and Disease 2010, 7:851-856.
10. Carey-Smith G.V., Billington C., Cornelius A.J., Heinnemann J.A. Isolation and characterization of bacteriophages infecting Salmonella spp. FEMS Microbiology Letters 2006, 258:182-186.
11. Cooke F.J., Brown D.J., Fookes M., Pickard D., Ivens A., Wain J., Roberts M., Kingsley R.A., Thomson N.R., Dougan G. Characterization of the genomes of a diverse collection of Salmonella enterica serovar Typhimurium definitive phage type 104. Journal of Bacteriology 2008, 190:8155-8162.
12. Fiorentin L., Vieira N.D., Barioni W. Oral treatment with bacteriophages reduces the concentration of Salmonella Enteritidis PT4 in caecal contents of broilers. Avian Pathology 2005, 34:258-263.
13. Fischetti V.A., Nelson D., Schuch R. Reinventing phage therapy: are the parts greater than the sum?. Nature Biotechnology 2006, 24:1508-1511.
14. Fluit A.C. Towards more virulent and antibiotic-resistant Salmonella?. FEMS Immunology and Medical Microbiology 2005, 43:1-11.
15. García P., Martínez B., Obeso J.M., Rodríguez A. Bacteriophages and their application in food safety. Letters in Applied Microbiology 2008, 47:479-485.
16. Goode D., Allen V.M., Barrow P.A. Reduction of experimental Salmonella and Campylobacter contamination of chicken skin by application of lytic bacteriophages. Applied and Environmental Microbiology 2003, 69:5032-5036.
17. Górski A., Weber-Dabrowska B. The potential role of endogenous bacteriophages in controlling invading pathogens. Cell and Molecular Life Sciences 2005, 62:511-519.
18. Guenther S., Huwyler D., Richard S., Loessner M.J. Virulent bacteriophage for efficient biocontrol of Listeria monocytogenes in ready-to-eat foods. Applied and Environmental Microbiology 2009, 75:93-100.
19. Hanlon G.W. Bacteriophages: an appraisal of their role in the treatment of bacterial infections. International Journal of Antimicrobial Agents 2007, 30:118-128.
20. Hendrix R.W. Bacteriophages: evolution of the majority. Theoretical Population Biology 2002, 61:471-480.
21. Housby J.N., Mann N.H. Phage therapy. Drug Discovery Today 2009, 14:536-540.
22. Johnson R.P., Gyles C.L., Huff W.E., Ojha S., Huff G.R., Rath N.C., Donoghue A.M. Bacteriophages for prophylaxis and therapy in cattle, poultry and pigs. Animal Health Research Reviews 2008, 9:201-215.
23. Koch A.L. Evolution of temperate pathogens: the bacteriophage/bacteria paradigm. Virology Journal 2007, 4:121.
24. Kocharunchitt C., Ross T., McNeil D.L. Use of bacteriophages as biocontrol agents to control Salmonella associated with seed sprouts. International Journal of Food Microbiology 2009, 128:453-459.
25. Kunisaki H., Tanji Y. Intercrossing of phage genomes in a phage cocktail and stable coexistence with Escherichia coli 0157:H7 in anaerobic continuous culture. Applied Microbiology and Biotechnology 2010, 85:1533-1540.
26. Labrie S.J., Samson J.E., Moineau S. Bacteriophage resistance mechanisms. Nature Reviews Microbiology 2010, 8:317-327.
27. Leverentz B., Conway W.S., Camp M.J., Janisiewicz W.J., Abuladze T., Yang M., Saftner R., Sulakvelidze A. Biocontrol of Listeria monocytogenes on fresh-cut produce by treatment with lytic bacteriophages and a bacteriocin. Applied and Environmental Microbiology 2003, 69:4519-4526.
28. Loynachan A.T., Harris D.L. Dose determination for acute Salmonella infection in pigs. Applied and Environmental Microbiology 2005, 71:2753-2755.
29. Mann N.H. The potential of phages to prevent MRSA infection. Research in Microbiology 2008, 159:400-405.
30. Matsuzaki S., Rashel M., Uchiyama J., Sakurai S., Ujihara T., Kuroda M., Ikeuchi M., Tani T., Fujieda M., Wakiguchi H., Imai S. Bacteriophage therapy: a revitalized therapy against bacterial infectious disease. Journal of Infection and chemotherapy 2005, 11:211-219.
31. Merabishvili M., Pirnay J.P., Verbaken G., Chanishvili N., Tediashvili M., Lashkhi N., Glonti T., Krylov V., Mast J., Parys L.V., Lavigne R., Volckaert G., Mattheus W., Verween G., De Corte P., Rose T., Jennes S., Zizi M., De Vos D., Vaneechoutte M. Quality-controlled small-scale production of a well-defined bacteriophage cocktail for use in human clinical trials. PLOS One 2009, 4:1-9.
32. Monk A., Rees C., Barrow P., Hagens S., Harper D. Bacteriophage applications: where are we now?. Letters in Applied Microbiology 2010, 51:363-369.
33. O' Flaherty S., Ross R.P., Coffey A. Bacteriophage and their lysins for elimination of infectious bacteria. FEMS Microbiology Review 2009, 2009:1-19.
34. O'Flynn G.O., Coffey A., Fitzgerald G.F., Ross R.P. The newly isolated lytic bacteriophages st104a and st104b are highly virulent against Salmonella enterica. Journal of Applied Microbiology 2006, 101:251-259.
35. Payne R.J.H., Jansen V.A.A. Phage therapy: the peculiar kinetics of self-replicating pharmaceuticals. Clinical Pharmacology and Therapeutics 2000, 68:225-230.
36. Perron G.G., Quessy S., Letellier A., Bell G. Genotypic diversity and antimicrobial resistance in asymptomatic Salmonella enterica serotype Typhimurium DT104. Infection, Genetics, and Evolution 2007, 7:223-228.
37. Santos S.B., Carvalho C.M., Sillankorva S., Nicolau A., Ferreira E.C., Azeredo J. The use of antibiotics to improve phage detection and enumeration by the double-layer agar technique. BMC Microbiology 2009, 9:148.
38. Scott A.E., Timms A.R., Connerton P.L., Loc Carrillo C., Radzum K.A., Connerton I.F. Genome dynamics of Campylobacter jejuni in response to bacteriophage predation. PLOS Pathogens 2007, 3:1142-1151.
39. Scott A.E., Timms A.R., Connerton P.L., El-Shibiny A., Connerton I.F. Bacteriophage influence Campylobacter jejuni types populating broiler chickens. Environmental Microbiology 2007, 9:2341-2353.
40. Sillankorva S., Pleteneva E., Shaburova O., Santos S., Carvalho C., Azeredo J., Krylov V. Salmonella Enteritidis bacteriophage candidates for phage therapy of poultry. Journal of Applied Microbiology 2010, 108:1175-1186.
41. Skurnik M., Strauch E. Phage therapy: facts and fiction. International Journal of Medical Microbiology 2006, 296:5-14.
42. Skurnik M., Pajunen M., Kiljunen S. Biotechnological challenges of phage therapy. Biotechnology Letters 2007, 29:995-1003.
43. St-Pierre F., Endy D. Determination of cell fate during phage lambda infection. PNAS 2008, 105:20705-20710.
44. Summers W.C. Bacteriophage therapy. Annual Review of Microbiology 2001, 55:437-451.
45. Toro H., Price S.B., McKee S., Hoerr F.J., Krehling J., Perdue M., Baeurmeister L. Use of bacteriophages in combination with competitive exclusion to reduce Salmonella from infected chickens. Avian Diseases 2005, 49:118-124.
46. Vigre H., Larsen P.B., Andreason M., Christensen J., Jorsal S.E. The effect of discontinued use of antimicrobial growth promoters on the risk of therapeutic antibiotic treatment in Danish farrow-to-finish pig farms. Epidemiology and Infection 2008, 136:92-107.
47. Villafane R., Zayas M., Gilcrease E.B., Kropinski A.M., Casjens S.R. Genomic analysis of bacteriophage Ε34 of Salmonella enterica serovar Anatum (15+). BMC Microbiology 2008, 8:227.
48. VLA Salmonella in Livestock Production in GB. Chapter 2.3 Reports of Salmonella in Pigs 2009, http://www.defra.gov.uk/vla/reports/docs/rep_salm08_chp2_3.pdf.
49. VLA Salmonella in Livestock Production in GB. Chapter 6 Antimicrobial Resistance in Salmonellas 2009, http://www.defra.gov.uk/vla/reports/docs/rep_salm08_chp6.pdf.
50. von Jagow C., Teufer T. Which path to go?. European Food and Feed Law Review 2007, 3:136-145.
51. Wall S.K., Zhang J., Rostagno M.H., Ebner P.D. Phage therapy to reduce pre-processing Salmonella infections in market weight swine. Applied and Environmental Microbiology 2010, 76:48-53.
52. Whichard J.M., Weigt L.A., Borris D.J., Li L.L., Zhang Q., Kapur V., Pierson F.W., Lingohr E.J., She Y.M., Kropinski A.M., Sriranganathan N. Complete genomic sequence of bacteriophage Felix 01. Viruses 2010, 2:710-730.